Expression of IL-10 in human normal and cancerous ovarian tissues and cells

European Cytokine Network

Volumn 21, Issue 2, 2010, Pages 122-128

  Rabinovich, Alex ^a,b   Medina, Liat ^b   Piura, Benjamin ^a,b   Huleihel, Mahmoud ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

IL 10; Il 10 mRNA; Il 10 receptor; Ovarian carcinoma; Primary cell line; SKOV 3

Indexed keywords

INTERLEUKIN 10; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER TISSUE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; OVARY CARCINOMA; PROTEIN EXPRESSION; TISSUE HOMOGENATE; TUMOR MICROENVIRONMENT;

CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; OVARIAN NEOPLASMS; OVARY; RECEPTORS, INTERLEUKIN-10; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77953892707     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2010.0188     Document Type: Article

References (32)

1. Cannistra SA. Cancer of the ovary. N Engl J Med 2004; 351: 2519-29.
2. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002; 20: 1248-59.
3. Santin AD, Bellone S, Ravaggi A, et al. Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer. BJOG 2001; 108: 804-8.
4. Nash MA, Ferrandina G, Gordinier M, Loercher A, Freedman RS. The role of cytokines in both the normal and malignant ovary. Endocr Relat Cancer 1999; 6: 93-107. (Pubitemid 29197233)
5. Moore KW. deWaal Malefyt R, Coffman RL and O'Garra A. Interleukin-10 and the Interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
6. Zhou J, Ye F, Chen H, Lv W, Gan N. The expression of interleukin-10 in patients with primary ovarian epithelial carcinoma and in ovarian carcinoma cell lines. J Int Med Res 2007; 35: 290-300. (Pubitemid 46971349)
7. Huleihel M, Maymon E, Piura B, et al. Distinct patterns of expression of interleukin-1 alpha and beta by normal and cancerous human ovarian tissues. Eur Cytokine Netw 1997; 8: 179-87. (Pubitemid 28152144)
8. Glezerman M, Mazot M, Maymon E, et al. Tumor necrosis factor-alpha and interleukin-6 are differently expressed by fresh human cancerous ovarian tissue and primary cell lines. Eur Cytokine Netw 1998; 9: 171-9. (Pubitemid 28301576)
9. Rabinovich A, Medina L, Piura B, Segal S, Huleihel M. Regulation of ovarian carcinoma SKOV-3 cell proliferation and secretion of MMPs by autocrine IL-6. Anticancer Res 2007; 27: 267-72. (Pubitemid 46363341)
10. Mocellin S, Wang E, Marincola FM. Cytokines and immune response in the tumor microenvironment. J Immunother 2001; 24: 392-407. (Pubitemid 33029909)
11. Vicari AP, Trinchieri G. Interleukin-10 in viral diseases and cancer: exiting the labyrinth? Immunol Rev 2004; 202: 223-36.
12. Berger S, Siegert A, Denkert C, Kobel M, Hauptmann S. Interleukin-10 in serous ovarian carcinoma cell lines. Cancer Immunol Immunother 2001; 50: 328-33. (Pubitemid 32757465)
13. Cervenak L, Morbidelli L, Donati D, et al. Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. Blood 2000; 96: 2568-73.
14. Stearns ME, Rhim J, Wang M. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion. Clin Cancer Res 1999; 5: 189-96.
15. Mustea A, Konsgen D, Braicu EI, et al. Expression of IL-10 in patients with ovarian carcinoma. Anticancer Res 2006; 26: 1715-8.
16. Mustea A, Braicu EI, Koensgen D, et al. Monitoring of IL-10 in the serum of patients with advanced ovarian cancer: Results from a prospective pilot-study. Cytokine 2009; 45: 8-11.
17. Gotlieb WH, Abrams JS, Watson JM, et al. Presence of IL-10 in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine 1992; 4: 385-90.
18. Kim J, Modlin RL, Moy RL, et al. IL-10 production in cutaneous basal and squamous cell carcinomas: a mechanism for evading the local T cell immune response. J Immunol 1995; 155: 2240-7.
19. Chen LL, Ye F, Lü WG, Yu Y, Chen HZ, Xie X. Evaluation of immune inhibitory cytokine profiles in epithelial ovarian carcinoma. J Obstet Gynaecol Res 2009; 35: 212-8.
20. Szlosarek PW, Balkwill FR. Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol 2003; 4: 565-73.
21. Merogi AJ, Marrogi AJ, Ramesh R, Robinson WR, Fermin CD, Freeman SM. Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas. Hum Pathol 1997; 28: 321-31. (Pubitemid 27106085)
22. Pisa P, Halapi E, Pisa EK, et al. Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colonystimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 1992; 89: 7708-12.
23. Brewer G, Saccani S, Sarkar S, Lewis A, Pestka S. Increased interleukin-10 mRNA stability in melanoma cells is associated with decreased levels of A + U-rich element binding factor AUF1. J Interferon Cytokine Res 2003; 23: 553-64. (Pubitemid 37323677)
24. Kohno T, Mizukami H, Suzuki M, et al. Interleukin-10-mediated Inhibition of Angiogenesis and Tumor Growth in Mice Bearing VEGF-producing Ovarian Cancer. Cancer Res 2003; 63: 5091-4.
25. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991; 174: 1549-55.
26. Yue FY, Dummer R, Geertsen R, et al. Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer 1997; 71: 630-7.
27. Fiorentino DF, Zlotnik A, Vieira P, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444-51.
28. Beissert S, Hosoi J, Grabbe S, et al. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Immunol 1995; 154: 1280-6.
29. Ding L, Linsley PS, Huang LY, et al. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993; 151: 1224-34.
30. Enk AH, Angeloni VL, Udey MC, et al. Inhibition of Langerhans cell antigenpresenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol 1993; 151: 2390-8.
31. Salazar-Onfray F. Interleukin-10: a cytokine used by tumors to escape immunosurveillance. Med Oncol 1999; 16: 86-94.
32. Malik S, Balkwill F. Epithelial ovarian cancer: a cytokine propelled disease? Br J Cancer 1991; 64: 617-20.